CGRP Inhibitors for Migraine.

Mohanty, Diksha; Lippmann, Steven

Mohanty, Diksha; Lippmann, Steven.

Afiliação

Mohanty D; Dr. Mohanty is a Neurology Resident Physician, and Dr. Lippmann is a Psychiatry Emeritus Professor at the University of Louisville School of Medicine in Louisville, Kentucky.
Lippmann S; Dr. Mohanty is a Neurology Resident Physician, and Dr. Lippmann is a Psychiatry Emeritus Professor at the University of Louisville School of Medicine in Louisville, Kentucky.

Innov Clin Neurosci ; 17(4-6): 39-40, 2020 Apr 01.

Article em En | MEDLINE | ID: mdl-32802591

ABSTRACT

ABSTRACT

Migraine headaches remain a significant medical concern; lots of people are adversely affected. Many existing pharmacotherapies have disappointing results. The pathophysiology is related to calcitonin gene-related peptide (CGRP) pathways. There is hope for better efficacy from the now-available CGRP inhibitor drugs made available to patients suffering these cephalgias.

Palavras-chave

CGRP inhibitor; Migraine; calcitonin-gene related peptide; chronic migraine; episodic migraine; erenumab; gepants; headache; monoclonal antibody

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article